{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:43:30Z","timestamp":1781070210053,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.yexcr.2018.08.013","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T02:18:43Z","timestamp":1534299523000},"page":"214-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["BRMS1L suppresses ovarian cancer metastasis via inhibition of the \u03b2-catenin-wnt pathway"],"prefix":"10.1016","volume":"371","author":[{"given":"Penglong","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juebin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2018.08.013_bib1","first-page":"87","article-title":"Global cancer statistics","volume":"65","author":"Jemal","year":"2011","journal-title":"Ca A Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2018.08.013_bib2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc2946","article-title":"The genesis and evolution of high-grade serous ovarian cancer[J]","volume":"10","author":"Bowtell","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2018.08.013_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrc1611","article-title":"Ovarian cancer metastasis: integrating insights from disparate model organisms","volume":"5","author":"Naora","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2018.08.013_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2018.08.013_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial\u2013 mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2018.08.013_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yexcr.2017.01.022","article-title":"miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1\/Notch2 pathway stimulating EMT","volume":"352","author":"Chen","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2018.08.013_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial\u2013 mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2018.08.013_bib8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1517\/14728222.2011.577418","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in human cancers","volume":"15","author":"Yao","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.yexcr.2018.08.013_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)65148-6","article-title":"\u03b2-Catenin Expression Pattern in Stage I and II Ovarian Carcinomas[J]","volume":"155","author":"Gamallo","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2018.08.013_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0090-8258(02)00015-X","article-title":"\u03b2-catenin nuclear localization is associated with grade in ovarian serous carcinoma","volume":"88","author":"Lee","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2018.08.013_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ejca.2005.01.022","article-title":"beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients","volume":"41","author":"Kildal","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexcr.2018.08.013_bib12","first-page":"264","article-title":"Overexpression of \u03b2-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas","volume":"7","author":"Wang","year":"2014","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"10.1016\/j.yexcr.2018.08.013_bib13","doi-asserted-by":"crossref","first-page":"e94476","DOI":"10.1371\/journal.pone.0094476","article-title":"Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease","volume":"9","author":"Brodsky","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.yexcr.2018.08.013_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"Alvero","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.yexcr.2018.08.013_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fonc.2014.00053","article-title":"A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population","volume":"4","author":"Mccloskey","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2018.08.013_bib16","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/onc.2012.290","article-title":"c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt|[sol]||[beta]|-catenin|[ndash]|ATP-binding cassette G2 signaling","volume":"32","author":"Chau","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2018.08.013_bib17","doi-asserted-by":"crossref","unstructured":"L. Rosan\u00f2, R. Cianfrocca, S. Masi, Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis, Proceedings of the National Academy of Sciences of the United States of America, 106, 2009, pp. 2806\u20132811.","DOI":"10.1073\/pnas.0807158106"},{"key":"10.1016\/j.yexcr.2018.08.013_bib18","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/onc.2014.178","article-title":"Beta-catenin regulated ALDH1A1 is a target in ovarian CancerSpheroids","volume":"34","author":"Condello","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2018.08.013_bib19","doi-asserted-by":"crossref","first-page":"23720","DOI":"10.18632\/oncotarget.4690","article-title":"Critical role of Wnt\/\u03b2-catenin signaling in driving epithelial ovarian cancer platinum resistance","volume":"6","author":"Belur","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2018.08.013_bib20","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbrc.2004.08.227","article-title":"Identification of a novel homologue protein p40 as a component of the mSin3A\/p33(ING1b)\/ HDAC1 deacetylase complex","volume":"323","author":"Nikolaev","year":"2004","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.yexcr.2018.08.013_bib21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3892\/or.2011.1596","article-title":"Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression","volume":"27","author":"Sheng","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2018.08.013_bib22","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/0008-5472.CAN-12-2489","article-title":"BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferasep300","volume":"73","author":"Liu","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2018.08.013_bib23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/onc.2010.470","article-title":"Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis","volume":"30","author":"Li","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2018.08.013_bib24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/1471-2407-12-376","article-title":"Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival","volume":"12","author":"Cui","year":"2012","journal-title":"Bmc Cancer"},{"key":"10.1016\/j.yexcr.2018.08.013_bib25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2353\/ajpath.2008.070772","article-title":"BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process","volume":"172","author":"Phadke","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2018.08.013_bib26","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/bjc.2014.104","article-title":"Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer","volume":"110","author":"Balgkouranidou","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.yexcr.2018.08.013_bib27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1525-1438.2006.00547.x","article-title":"Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1","volume":"16","author":"Zhang","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.yexcr.2018.08.013_bib28","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1093\/nar\/gkh906","article-title":"Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors","volume":"32","author":"Hollenhorst","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2018.08.013_bib29","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1002\/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8","article-title":"Overexpression of p53 and prognosis in breast cancer","volume":"72","author":"Friedrichs","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.yexcr.2018.08.013_bib30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/bjc.1996.236","article-title":"Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues","volume":"73","author":"Chui","year":"1996","journal-title":"Br. J. Cance"},{"key":"10.1016\/j.yexcr.2018.08.013_bib31","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1038\/ncomms6406","article-title":"BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10","volume":"5","author":"Gong","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2018.08.013_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrc1611","article-title":"Ovarian Cancer Metastasis: integrating insights from disparate model organisms","volume":"5","author":"Naora","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2018.08.013_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2018.08.013_bib34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2018.08.013_bib35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ncb2976","article-title":"Oncogenic roles of EMT-inducing transcription factors","volume":"16","author":"Puisieux","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yexcr.2018.08.013_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2018.08.013_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fonc.2012.00033","article-title":"Epithelial-mesenchymal transition in ovarian carcinoma","volume":"2","author":"Davidson","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2018.08.013_bib38","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","article-title":"The Wnt\/\u03b2-catenin pathway in ovarian cancer: a review","volume":"131","author":"Arend","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2018.08.013_bib39","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/cas.13420","article-title":"Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53","volume":"108","author":"Koyama","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexcr.2018.08.013_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"Ca Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2018.08.013_bib41","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbamem.2007.12.015","article-title":"Molecular components of the adherens junction","volume":"1778","author":"Niessen","year":"2008","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.yexcr.2018.08.013_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/B978-0-12-394311-8.00014-5","article-title":"Cadherins and epithelial-to-mesenchymal transition","volume":"116","author":"Gheldof","year":"2013","journal-title":"Progress. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.yexcr.2018.08.013_bib43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijc.2910580315","article-title":"Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells","volume":"58","author":"Veatch","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2018.08.013_bib44","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0046-8177(97)90007-1","article-title":"Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases","volume":"28","author":"Dara\u00ef","year":"1997","journal-title":"Human. Pathol."},{"key":"10.1016\/j.yexcr.2018.08.013_bib45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cellsig.2006.11.001","article-title":"Multiplicity of the interactions of Wnt proteins and their receptors","volume":"19","author":"Kikuchi","year":"2017","journal-title":"Cell Signal."},{"key":"10.1016\/j.yexcr.2018.08.013_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110112","article-title":"Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment","volume":"437","author":"Barbolina","year":"2011","journal-title":"Biochem J."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448271830675X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448271830675X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T20:00:57Z","timestamp":1604779257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448271830675X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S001448271830675X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2018.08.013","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRMS1L suppresses ovarian cancer metastasis via inhibition of the \u03b2-catenin-wnt pathway","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2018.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}